Growth Metrics

Aclarion (ACON) Long-Term Debt Repayments (2024)

Aclarion posted quarterly Long-Term Debt Repayments of -$1.0 for Q4 2024, down 200.0% on a QoQ basis from $1.0 in Q3 2024.

Aclarion (ACON) has 1 years of Long-Term Debt Repayments data on file, last reported at -$1.0 in Q4 2024.

  • For the quarter ending Q4 2024, Long-Term Debt Repayments changed N/A year-over-year to -$1.0; the trailing twelve-month figure through Sep 2025 stood at -$1.0 (down 100.0% YoY), and the FY2024 full-year result was $300973.0, changed N/A from the prior year.
  • Long-Term Debt Repayments for Q4 2024 stood at -$1.0, down from $1.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $300974.0 in Q1 2024 and bottomed at -$1.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.35 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 15.00 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 23.55 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Aclarion 7.18 Mn -11.57 Mn 3,750.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -1.00
Dec 31, 2024 -1.00
Sep 30, 2024 1.00
Sep 30, 2024 1.00
Jun 30, 2024 -1.00
Jun 30, 2024 -1.00
Mar 31, 2024 300,974.00
Mar 31, 2024 300,974.00